P-076 The impact of heterogeneous disease distribution on MRD detection in patients with relapsed multiple myeloma
Lukas John(University of Hohenheim), Niels Weinhold(German Cancer Research Center), Philipp Reichert(Heidelberg University), Stefanie Huhn(Heidelberg University), Carsten Müller‐Tidow(Heidelberg University), Ricarda Schwab(Heidelberg University), Ewelina Nickel(Heidelberg University), Jan Frenking(German Cancer Research Center), Christian Michel(Fund for Scientific Research), Sabine Quick(Heidelberg University), Christos Sachpekidis(Democritus University of Thrace), Stefan Schönland(Heidelberg University), Lilli Sester, Stefan Delorme(German Cancer Research Center), Joseph Kauer, Calin-Petru Manta(Heidelberg University), Martin Grözinger(German Cancer Research Center), Marc S. Raab(Unknown), Sandra Sauer(Heidelberg University), Mirco Friedrich(Broad Institute), Michael Hundemer(Heidelberg University), Antonia Dimitrakopolou-Straus(German Cancer Research Center), Schneiders Birgit(Heidelberg University), Barbara Wagner(Heidelberg University), Uwe Haberkorn(German Cancer Research Center)
Cited by 0
Related Papers
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
|Journal of Clinical Oncology|2012|965
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein
|Journal of Nuclear Medicine|2018|908
Systemic immunoglobulin light chain amyloidosis
|Nature Reviews Disease Primers|2018|550